Spring til hovednavigation Spring til søgning Spring til hovedindhold

Miriam Kolko

Professor in Translational Eye Research, Institut for Lægemiddeldesign og Farmakologi, Københavns Universitet, Overlæge, Oftalmologisk afdeling, Københavns Universitetshospital, Rigshospitalet-Glostrup, Leder af Eye Translational Research Unit, , Institut for Lægemiddeldesign og Farmakologi, Københavns Universitet, Leder af Personalized Medicine Research Cluster, Institut for Lægemiddeldesign og Farmakologi, Københavns Universitet

  • Universitetsparken 2

    2100 København Ø

Personlig profil

Kort præsentation

Professor Miriam Kolko er overlæge og grøn stærspecialist ved Københavns Universitetshospital, Rigshospitalet og professor i translationel øjenforskning ved Institut for Lægemiddeldesign og Farmakologi på Københavns Universitet. Hun er også formand for Dansk Glaucom forening b og bestyrelsesmedlem i Fight for Sight, Danmark. Derudover er professor Kolko glaukom-formand for EVER, hun sidder i WGA Associate Advisory Board er co-formand for EGS neuroprotection SIG.


På Københavns Universitet leder professor Kolko forskningssektionen Translational and Clinical Pharmacology og forskningsgruppen Eye Translational Research Unit, EyeTRU. Som kliniker og forsker bygger hun bro mellem at opretholde en klinisk karriere med glaukompatienter og at undersøge grundlæggende, translationelle og kliniske forskningsmodeller, der hjælper med at forstå patofysiologien af glaukom og forbedre glaukombehandlingen.

CV

work addresses

  • Afdeling for Øjensygdomme (Department of Ophthalmology), Rigshospitalet, Valdemar Hansens Vej 1-23, 2600 Glostrup
  • Institut for Lægemiddeldesign og Farmakologi (Department of Drug Design and Pharmacology), Universitetsparken 2, 2100 Copenhagen

positions and trusted postures

  • Professor in Translational Eye Research at University of Copenhagen (UCPH)
  • Chief Physician (glaucoma specialist) at the Copenhagen University Hospital (Rigshospitalet)
  • Fellow of the European Board of Ophthalmology, Glaucoma (FEBOS-GL)
  • President of the Danish Glaucoma Society 
  • Board member of Fight for Sight, Denmark
  • Elected glaucoma chair European Association for Vision and Eye Research, EVER
  • Elected member of board of directors Acta Ophthalmologica
  • Elected member of Associate Advisory Board (AAB), World Glaucoma Association
  • Co-Chair of neuroprotection special interest group, European Glaucoma Society (EGS)
  • Part of the management team at Dept. of Drug Design and Pharmacology (DDP), UCPH
  • Member of the research strategy committee, Dept. of Ophthalmology, Rigshospitalet
  • Head of Research Cluster for Personalised Medicine, DDP, UCPH
  • Head of Research Group, Eye Translational Research Unit, EyeTRU, UCPH
  • National and international coordinator of multicenter studies within glaucoma disease research.
  • Jury member of funding applications from national research council's (Belgium and Canada) and several other national and international foundations
  • Board Member of Carl and Nicoline Larsen’s Foundation
  • Member of assessment committee and chair of committees for the appointment of assistant, associate, and full professors
  • Editorial board member (e.g. Molecular Neurobiol., Cell. and Mol. Neurobiol., Acta Ophthal.)
  • Director of glaucoma in the Region of Zealand (2014-2017).
  • Head of Section at the Dept. of Drug Design and Pharmacology, UCPH (2018-2019).

Education

  • Medical Doctor degree, University of Copenhagen.
  • Fulbright Scholar, Louisiana State University (LSU), Neuroscience Center, US
  • PhD from LSU, Neuroscience Center and Dept. of Ophthalmology, US.
  • Postdoctoral Fellowships at Louisiana State University, Neuroscience Center, US.
  • Postdoctoral Fellowship at UCPH, Dept. of Ocular Pathology.
  • Medical Internships in surgery, emergency medicine, and ophthalmology in the Region of Copenhagen.
  • Residency in Ophthalmology in the Region of Copenhagen.
  • Fellowship in Glaucoma at the Copenhagen University Hospital.
  • Clinical exchanges in glaucoma in US (New York, Sacramento), Belgium (Leuven), India (Madurai)
  • More courses in pedagogy
  • Fellow of the EuropeanBoard of Ophthalmology, Glaucoma
  • Several leadership and management courses

Selected awards, honors and recognitions

  • Top 1% of scholars writing about Glaucoma, Expertscape's PubMed-based algorithms
  • On the Ophthalmologist's Power List, 2021
  • Received the largest grant to date from the Synoptik Foundation
  • Lions prize, 2018
  • Award of Excellence from the Danish Ophthalmological Society, 2018
  • Medivit Award, 2014 and 2016
  • Victor Larsens Award, 2006
  • Fulbright Scholar, 1995
  • Awarded research funding of >25 million DKK (>3.3 mill EUR)
  • Invited speaker, hereunder keynotes and honorary, at more than 80 scientific meetings

project management, guidance and academic results

  • I head translational research projects within the field of neurodegenerative eye diseases
  • I am national coordinator of clinical multicenter studies within glaucoma
  • I have successfully supervised 5 postdocs, 5 PhD students (3 as main supervisor), 3 research assistants, 21 master students, 16 scholar students, and 19 bachelor students
  • I currently supervise 10 PhD students (8 as main supervisor, 2 as co-supervisor), 3 master students, 1 bachelor student
  • I have more than 100 peer-reviewed papers,10 editorial reviews, 22 popular science papers, and 7 book chapters.

My involvement in the field of medicine and key research areas

  • I direct course work for medical students, residents in ophthalmology, and pharmacy students
  • I consult eye patients, including medical treatment, laser treatments and glaucoma surgeries
  • I organize seminars, conferences, and public events to facilitate collaborations and community outreach activities
  • I have several leadership roles and continuously try to create a transparent, trustworthy, and authentic work environment with motivated students, coworkers, and staff
  • I function as an opinion leader and as an external advisor to the pharma industry
  • I am national coordinator/principal investigator of more industry-sponsored clinical trials
  • I am engaged in outreach activities to improve treatment and diagnostic strategies for patients

This is an abbreviated resume of my full CV - full CV available upon request.

Uddannelse (Akademiske kvalifikationer)

FEBOS-GL

Dimissionsdato: 1 apr. 2022

Speciallæge i øjensygdomme

Dimissionsdato: 1 okt. 2010

PhD, PhD

Dimissionsdato: 16 dec. 2003

Medicine, læge

Dimissionsdato: 28 jan. 2000

Eksterne ansættelser

Formand for Dansk GlaukomSelskab

9 mar. 2018 → …

Samarbejde og topforskningsområder i de sidste fem år

Seneste eksterne samarbejde på lande-/områdeniveau. Dyk ned i detaljerne ved at klikke på prikkerne eller